Journal Articles

Molecular target and action mechanism of anti-cancer agents

Lead Editor:
    Professor Seok-Geun Lee Kyung Hee University Republic of Korea


Recent advances in genomics, proteomics, and metabolomics are changing the way physicians and scientists approach the diagnosis and treatment of cancer. Increased knowledge of cancer diagnosis with more detailed stratification based on patient omics data helps to move the field of precision oncology forward. In addition, developing new anti-cancer drugs targeting genetic changes is another important part of precision oncology. In this context, this Special Issue aims to cover molecular-mechanism-based research for anticancer therapy. It welcomes original research, and review articles on the discovery of molecular targets or/and molecular mechanisms of any anti-cancer agents, including conventional chemotherapy, novel potential anti-cancer drug candidates, and their combinations with any other anti-cancer modalities.


Submission deadline:

28/12/2024


Article Special Issue Open Access

Comprehensive transcriptomic profiling of liver cancer identifies that histone and PTEN are major regulators of SCU‑induced antitumor activity

Sang Eun Ha, Anjugam Paramanantham, Hun Hwan Kim, Pritam Bhagwan Bhosale, Min Yeong Park, Abuyaseer Abusaliya, Jeong Doo Heo, Won Sup Lee, Gon Sup Kim

Article Number: 94 Published online on: 11 January 2024
Article Special Issue Open Access

Ramucirumab in second‑line advanced colorectal cancer therapy: A study on therapeutic outcomes and hepatic sinusoidal platelet aggregation

Keisuke Kimura, Yosuke Katata, Yuzo Umeda, Takehiro Tanaka, Shuya Yano, Kazuhiro Yoshida, Toshiyoshi Fujiwara, Yoshiko Mori, Takeshi Yamada, Takeshi Nagasaka

Article Number: 439 Published online on: 15 July 2024

Print ISSN: 1792-1074
Online ISSN: 1792-1082

Sign up for eToc alerts

Recommend to Library